Criticalkare Pharma

Rahika 200mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change (mutation) in a gene that makes an enzyme called MET in adults.  
Do not take this medicine if you are allergic to Rahika 200mg tablet or any ingredients. Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you have any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents below 18 years of age.

Uses
Non-small cell lung cancer (NSCLC)
Storage
Store at 20°C to 25°C

Side Effects
Swelling in the face, and bodyDecrease in appetiteNauseaCoughFatigue VomitingLiver injuryMuscle painShortness of breathLung infectionRespiratory disease

Sorafenat 200mg Tablet belongs to the anti-cancer group of medicines. It consists of the active ingredient Sorafenib, which is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients ineligible for surgery, and differentiated thyroid carcinoma (thyroid cancer) in patients who are not responsive to radioactive iodine therapy. 
Diarrhea, tiredness, stomach pain, nausea, weakness, rashes, flu-like illness, appetite loss, nausea, weight loss, and low blood calcium levels are common side effects of Sorafenat 200mg Tablet. Inform your doctor if any of these side effects disturb or persist with you.

Uses
Advanced renal cell carcinomaAdvanced hepatocellular carcinoma that cannot be surgically treatedAdvanced papillary and follicular Hurtle cell thyroid carcinoma

Storage
Store below 30°C in a dry place.

Side Effects
Stevens Johnsons Syndrome and toxic epidermal necrosisDecreased blood flow to the heartIncreased risk of bleeding (blood in urine, stool, vomit, cough, etc.)High BPSkin problemsLiver problemsProblems in wound healingNausea, stomach pain, diarrheaTiredness and weaknessInfectionHair thinning and patchy hair lossRashWeight lossLoss of appetiteLow levels of calcium in the bloodFlu-like illness

Soranib 200mg Tablet belongs to the group of medicines called anti-cancer. It consists of the active ingredient Sorafenib which is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients ineligible for surgery, and differentiated thyroid carcinoma (thyroid cancer) in patients who are not responsive to radioactive iodine therapy.  
Diarrhea, tiredness, stomach pain, nausea, weakness, rashes, flu-like illness, appetite loss, nausea, weight loss, and low blood calcium levels are common side effects of Soranib 200mg Tablet. Inform your doctor if any of these side effects disturb or persist with you.

Uses
Advanced renal cell carcinomaAdvanced hepatocellular carcinoma that cannot be surgically treatedAdvanced papillary and follicular Hurtle cell thyroid carcinoma

Storage
Store below 30°C in a dry place.

Side Effects
Stevens Johnsons Syndrome and toxic epidermal necrosisDecreased blood flow to the heartIncreased risk of bleeding (blood in urine, stool, vomit, cough, etc)High BPSkin problemsLiver problemsProblems in wound healingNausea, stomach pain, diarrheaTiredness and weaknessInfectionHair thinning and patchy hair lossRashWeight lossLoss of appetiteLow levels of calcium in the bloodFlu-like illness

Kryxana 200mg Tablet is an anticancer medication containing the active ingredient ribociclib. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is used in women to treat a type of breast cancer (hormone receptor-positive, HER2-negative breast cancer) that is locally advanced or has spread to other parts of the body.  This medication is given in combination with other medications. It can also be used in the treatment of endometrial cancer in combination with other drugs. It works by inhibiting the activity of certain proteins, which regulate cell growth and division. By blocking these proteins, it can slow down or stop the growth of cancer cells.

Uses
Advanced or metastatic breast cancerAdvanced or metastatic endometrial cancer

Storage
Kryxana 200mg Tablet tablets should be stored at room temperature between 20°C and 25°C (68°F and 77°F).It should be kept dry and protected from light and moisture.The tablets should be kept in the original packaging with the cap tightly closed.

Side Effects
DehydrationKidney problemsElectrolyte imbalancesLiver damagePneumonitis (inflammation of the lung wall)Difficulty in breathingChest painDiarrhoeaNauseaVomitingFatigueDecreased appetiteAbdominal painHeadacheRespiratory tract infectionsAnaemiaIncreased risk of infectionsLow white blood cell countLow platelet count

Jakavi 20mg tablet contains the active constituent ruxolitinib. It is an anticancer agent that belongs to the class of kinase inhibitors. It is used to treat myelofibrosis (a rare type of bone marrow cancer that causes decreased blood cell production). It is also used to treat polycythemia vera (a type of blood cancer where the body produces too many red blood cells) in people who are resistant or cannot be treated successful hydroxyurea. The medicine is also indicated to treat acute graft versus host disease (a complication of transplant procedure that replaced diseased bone marrow with healthy bone marrow) previously treated unsuccessfully with steroid medications in adults and children 12 years of age. It is also used for treating chronic graft versus host disease in adults and children 12 years of age and older who were treated unsuccessfully with 1 or 2 other systemic treatments.

Uses
MyelofibrosisPolycythemia veraAcute-graft-versus host diseaseChronic-graft-versus host disease

Storage
Do not store this medicine above 30°C

Side Effects
Severe infections like hepatitis BAnemiaBleeding
Low red and white blood cell countsLow platelet countsDizziness, headacheBruisingDiarrheaInfections including viral infectionSwelling in the face and bodyFatigue or tiredness

Ideenat 100mg tablet is an antineoplastic drug with an active ingredient called Idelalisib. It belongs to the medication class known as PI3K Inhibitors. It is used to treat chronic lymphocytic leukemia (CLL) in adults in combination with Rituximab. This medicine is given to those who have received medicine at least once in previous or patient's cancer cells with a genetic mutation named 17p deletion or TP53 and who are not eligible for other therapies. Additionally, this medicine is used for treating adult patients with follicular lymphoma as monotherapy. It is not recommended for those younger than 18 years.  
Do not consume Ideenat 100mg tablets if you are allergic to Idelalisib, sunset yellow FCF (a petroleum-derived orange azo dye), and other ingredients of this medicine. Inform your physician if you have any conditions with the liver, lung (pneumonitis), kidney, intestinal perforation, neutropenia (low level of neutrophils), active infections/hepatitis, or skin reaction (Stevens-Johnson syndrome). Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after a month of treatment. Discuss more fertility concerns with your doctor. Your doctor will take regular blood tests before and during treatment to monitor the infections.

Uses
Chronic lymphocytic leukemia (CLL) in adultFollicular lymphoma

Storage
Store protected from light at a temperature not exceeding 30°C.Do not freeze.  

Side Effects
Reddish patchChanges in the skin colorSkin-peeling Mouth ulcerUlcer in throat, nose, genital, and eyeSkin rashesFeverDRESS syndrome (enlarged lymph nodes)InfectionsLiver damageChange in the number of WBCIncreased liver enzymesLung inflammation

Ideenat 150mg tablet is an antineoplastic drug with an active ingredient called Idelalisib. It belongs to the medication class known as PI3K Inhibitors. It is used to treat chronic lymphocytic leukemia (CLL) in adults in combination with Rituximab. This medicine is given to those who have received medicine at least once in previous or patient's cancer cells with a genetic mutation named 17p deletion or TP53 and who are not eligible for other therapies. Additionally, this medicine is used for treating adult patients with follicular lymphoma as monotherapy. It is not recommended for those younger than 18 years.  
Do not consume Ideenat 150mg tablets if you are allergic to Idelalisib, sunset yellow FCF (a petroleum-derived orange azo dye), and other ingredients of this medicine. Inform your physician if you have any conditions with the liver, lung (pneumonitis), kidney, intestinal perforation, neutropenia (low level of neutrophils), active infections/hepatitis, or skin reaction (Stevens-Johnson syndrome). Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after a month of treatment. Discuss more fertility concerns with your doctor. Your doctor will take regular blood tests before and during treatment to monitor the infections.

Uses
Chronic lymphocytic leukemia (CLL) in adultFollicular lymphoma

Storage
Store protected from light at a temperature not exceeding 30°C.Do not freeze.   

Side Effects
Reddish patchChanges in the skin colorSkin-peeling Mouth ulcerUlcer in throat, nose, genital, and eyeSkin rashesFeverDRESS syndrome (enlarged lymph nodes)InfectionsLiver damageChange in the number of WBCIncreased liver enzymesLung inflammation

Tucanat 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
Tucatinib in Tucanat 150mg Tablet works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib helps slow down or stop the cancer from spreading further.
Tucatinib is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice, and regular checkups are needed during treatment to make sure the medicine is working safely.

Uses
HER2-positive advanced or metastatic breast cancer
Brain metastases in HER2+ breast cancer patients
Use in combination with trastuzumab and capecitabine after previous HER2-directed therapies
This therapy is typically considered when other standard HER2 treatments have become ineffective.

Storage
Store below 30°C in a dry place, away from direct sunlight.

Side Effects
Loose motion (diarrhea)
Feeling very tired
Nausea or vomiting
Mouth sores
Less hunger
Red or sore hands and feet
Liver test changes (seen in blood reports)
These usually go away with time or treatment. Tell your doctor if any feel too strong or last long.
For Serious Side Effects (Call Your Doctor Right Away)
Yellow skin or eyes (could mean a liver problem)
Bad diarrhea with weakness
Trouble breathing or swelling (could be an allergy)
High fever or infections
Report any unexpected or persistent side effects to your doctor immediately.

Tukavo 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
Tucatinib in Tukavo 150mg Tablet works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib helps slow down or stop the cancer from spreading further.
Tucatinib is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice, and regular checkups are needed during treatment to make sure the medicine is working safely.
UsesHER2-positive advanced or metastatic breast cancerBrain metastases in HER2+ breast cancer patientsUse in combination with trastuzumab and capecitabine after previous HER2-directed therapiesThis therapy is typically considered when other standard HER2 treatments have become ineffective.

Storage
Store below 30°C in a dry place, away from direct sunlight.

Side Effects
Loose motion (diarrhea)Feeling very tiredNausea or vomitingMouth soresLess hungerRed or sore hands and feetLiver test changes (seen in blood reports)These usually go away with time or treatment. Tell your doctor if any feel too strong or last long.If any below Serious Side Effects (Call Your Doctor Right Away)Yellow skin or eyes (could mean a liver problemBad diarrhea with weaknessTrouble breathing or swelling (could be an allergy)High fever or infectionsReport any unexpected or persistent side effects to your doctor immediately

Tuccatinn 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
Tucatinib in Tuccatinn 150mg Tablet works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib helps slow down or stop the cancer from spreading further.
Tucatinib is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice and regular checkups are needed during treatment to make sure the medicine is working safely.
UsesHER2-positive advanced or metastatic breast cancerBrain metastases in HER2+ breast cancer patientsUse in combination with trastuzumab and capecitabine after previous HER2-directed therapiesThis therapy is typically considered when other standard HER2 treatments have become ineffective.
Storage
Store below 30°C in a dry place, away from direct sunlight.

Side Effects
Loose motion (diarrhea)Feeling very tiredNausea or vomitingMouth soresLess hungerRed or sore hands and feetLiver test changes (seen in blood reports)These usually go away with time or treatment. Tell your doctor if any feel too strong or last long.If any below Serious Side Effects (Call Your Doctor Right Away)Yellow skin or eyes (could mean a liver problemBad diarrhea with weaknessTrouble breathing or swelling (could be an allergy)High fever or infectionsReport any unexpected or persistent side effects to your doctor immediately

Tucaone 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
Tucatinib in Tucaone 150mg Tablet works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib helps slow down or stop the cancer from spreading further.
Tucatinib is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice, and regular checkups are needed during treatment to make sure the medicine is working safely.
UsesHER2-positive advanced or metastatic breast cancerBrain metastases in HER2+ breast cancer patientsUse in combination with trastuzumab and capecitabine after previous HER2-directed therapiesThis therapy is typically considered when other standard HER2 treatments have become ineffective.
Storage
Store below 30°C in a dry place, away from direct sunlight.Keep in the original blister or bottle until ready to use.
Side Effects
Loose motion (diarrhea)Feeling very tiredNausea or vomitingMouth soresLess hungerRed or sore hands and feetLiver test changes (seen in blood reports)These usually go away with time or treatment. Tell your doctor if any feel too strong or last long.If any below Serious Side Effects (Call Your Doctor Right Away)Yellow skin or eyes (could mean a liver problemBad diarrhea with weaknessTrouble breathing or swelling (could be an allergy)High fever or infectionsReport any unexpected or persistent side effects to your doctor immediately

Tishtha 100mg Injection consists of the active substance Nivolumab. It is indicated to treat cancers of the skin, lungs, kidney, lymph node, bladder, oesophagus, and urinary tract. This medicine is indicated when the cancer has recurred after treatment using medicines, surgery, and radiation. It is a medication that helps the immune system fight cancer more effectively. It works by targeting and inhibiting specific molecules that can suppress or weaken the immune system's ability to recognize and attack cancer cells. By blocking these molecules, it helps to enhance the immune response against cancer and potentially shrink or slow the growth of tumours. 
One of the benefits of it and other immunotherapy drugs is that they can produce long-lasting responses in some patients, even after the treatment is stopped. This contrasts traditional chemotherapy and radiation therapy, which typically only provide temporary benefits and can have significant side effects. It is contraindicated in patients with a severe allergic reaction to the drug or its components. It is also contraindicated in patients with certain autoimmune disorders, such as lupus or rheumatoid arthritis because the drug can further stimulate the immune system and exacerbate these conditions. Additionally, it should be used cautiously in patients with a history of organ transplants.
UsesAdvanced skin cancer (melanoma)Skin cancer that recurs after surgeryAdvanced non-small cell lung cancerAdvanced kidney cancerHodgkin’s lymphoma (lymph node disease)Advanced cancer of the head and neckAdvanced urinary tract and bladder cancerAdvanced oesophageal cancer
Storage
Tishtha 100mg Injection is typically supplied in vials or pre-filled syringes and should be stored at controlled room temperature between 20-25°C (68-77°F).
The drug should be protected from light and should not be frozen.
Once the vial or syringe is opened, any unused portion should be discarded. It is important to follow the manufacturer's instructions for handling and storage of it to ensure that the drug is effective and safe for use.
Keep it out of reach from children and pets.
Side Effects
Serious:Pneumonitis (inflammation of lung tissue)Colitis (inflammation of the colon)Hepatitis (inflammation of the liver)HypothyroidismHyperthyroidismAdrenal insufficiency (a condition in which the adrenal glands do not produce enough hormones).Severe allergic reactionsInfusion-related reactionsConfusionSeizuresNeuropathyEye disorders (such as uveitis or iritis)
Common:FatigueNauseaSkin rashItchingLoss of appetiteDiarrhoeaConstipationJoint painHeadache

Adriamycin 50mg Injection is a  chemotherapy drug containing the active constituent doxorubicin.  It belongs to the medication class known as  cytotoxic agents. It treats many types of cancers, such as lung, breast, blood, bladder, stomach, etc. It may be given alone or in combination with other anticancer medicines. Cancer is a condition in which cells multiply uncontrolled and abnormally.
Before starting treatment with Adriamycin 50mg Injection, it is very important to tell your physician if you have or had any history of  severe heart disorders, liver disorders, and hypersensitivity. Notify your doctor if you are taking or have ever received certain cancer chemotherapy medications. Avoid live vaccines during the treatment.

Uses
Breast cancerLung cancerMalignant lymphomasCertain types of leukemia

Storage
Store refrigerated at 2°C to 8°C. Do not freeze.

Side Effects
Low white blood cell countSevere allergic reaction (shortness of breath, dizziness, itchy rash, tightness in chest or throat)Decreased activity in the bone marrowIncrease the level of liver enzymeLack of appetiteNausea, vomitingDiarrheaHair lossSwelling in the mouth and ankleNumbness, pain, tingling, swelling, or reddening in the palms and feetWeight gainArrhythmia (irregular heartbeats)Red or watery eyes, excess tear production

Altraz 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. It is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.

Uses
Hormone-dependent breast cancer in postmenopausal women.

Storage
Keep the tablets away from light and moisture.Store at room temperature not exceeding 30°C.

Side Effects
Hypersensitive skin rash.Swelling of small blood vessels.Difficulty breathing and swallowing.Severe skin rash with blisters or ulcers, which is called Stevens-Johnson syndrome. Loss of appetiteVaginal bleeding and drynessBone loss (Osteoporosis)Inflammation of the joints (arthritis)Diarrhea, NauseaDepressionMuscle painAllergic hypersensitivityBone painTingling, pain, coldness, weakness in parts of the hand.Hair thinning

Anabrez 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. It is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.

Uses
Hormone-dependent breast cancer in postmenopausal women.

Storage
Keep the tablets away from light and moisture.Store at room temperature not exceeding 30°C.

Side Effects
Hypersensitive skin rash.Swelling of small blood vessels.Difficulty breathing and swallowing.Severe skin rash with blisters or ulcers, which is called Stevens-Johnson syndrome.Loss of appetiteVaginal bleeding and drynessBone loss (Osteoporosis)Inflammation of the joints (arthritis)Diarrhea, NauseaDepressionMuscle painAllergic hypersensitivityBone painTingling, pain, coldness, weakness in parts of the hand.Hair thinning

Armotraz 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. It is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.

Uses
Hormone-dependent breast cancer in postmenopausal women.

Storage
Store at room temperature not exceeding 30°C.

Side Effects
Hypersensitive skin rash.Swelling of small blood vessels.Difficulty breathing and swallowing.Severe skin rash with blisters or ulcers, which is called Stevens-Johnson syndrome.Loss of appetiteVaginal bleeding and drynessBone loss (Osteoporosis)Inflammation of the joints (arthritis)Diarrhea, NauseaDepressionMuscle painAllergic hypersensitivityBone painTingling, pain, coldness, weakness in parts of the hand.Hair thinning

Capnat 500mg Tablet contains the active ingredient Capecitabine. It belongs to the category of medicines known as antimetabolites. This medication is used in combination with other anticancer drugs for the treatment of Metastatic colorectal cancer and breast cancer. Cancer is a disease in which cells multiply in an abnormal and uncontrolled manner. It is also used for the prevention of new occurrences of cancer in the colon after the complete removal of the tumor by surgery.

Uses
Adjuvant colon cancerMetastatic colorectal cancerMetastatic breast cancer

Storage
Store Capnat 500mg Tablet in the original package at room temperature (20°C to 25°C). Do not freeze.

Side Effects
Severe bloody diarrhoea, abdominal painHeart problems (chest pain, shortness of breath, feeling faint, irregular heartbeat, sudden weight gain)Loss of too much body fluid, kidney failureSerious skin and mouth reactions (skin peeling, blisters)Hand and foot syndrome (swelling, changes in sensation of hands and feet)Liver problemsDecreased blood countLoss of appetiteWeight lossInsomnia, depressionHeadache, dizzinessEye irritation, redness, increased tearsInflammation of veinsRunny nose, feverInfectionsHair lossPain in joints, backDry mouth, indigestionConstipation

Geftinat 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Uses
Non-small cell lung cancer.

Storage
Store Geftinat 250mg Tablet in the original package at room temperature (25°C).

Side Effects 
diarrheanauseavomitingloss of appetiteweaknessred or sore mouthincreased liver enzymesitchy or cracked skindry mouthred or itchy eyesnail problemshair lossfeverblood in the urine and burning sensation while urinating

Nabcure 100mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count.

Uses
Ovarian cancerBreast cancerNon-small cell lung cancerAIDS-related Kaposi’s sarcoma

Storage
Do not store above 25°C.

Side Effects
Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)Severe diarrheaSevere stomach painAnemia, feeling tiredHair lossBurning, tingling, or numbness in your feet or handsMuscle and joint painVomiting, nauseaMouth or lip soresInfectionsSwelling of hands, feet, and faceBleedingIrritation at the injection siteLow blood pressure

Palnat 125mg Capsule is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications.  
The common side effects that are likely to associate with Palnat 125mg Capsule are nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persists in you.

Uses
Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.

Storage
Store at 20°C to 25°C.

Side Effects
Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)Lung inflammation (chest pain, dry cough, or difficulty breathing)TirednessHair lossDry skin, rashInfectionsLow blood cell countsDecreased of appetiteNausea, vomitingDiarrheaSwelling of lips and mouthChanges in tasteNose bleedDry eye, blurred vision, increased tearing

Zemasin 25mg tablet is an anticancer drug with the active ingredient Exemestane. It belongs to the medication class known as aromatase inhibitors. In postmenopausal women, it is used to treat hormone-dependent early breast cancer after completing 2-3 years of treatment with Tamoxifen. In addition, it also treats hormone-dependent advanced breast cancer.  Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Do not take this medicine if you are allergic to Exemestane or any of the other ingredients of this medicine and if you have not been through the menopause stage, also if you think you are pregnant or breastfeeding.

Uses
Breast cancer

Storage
This medicine does not require any special storage conditions.

Side Effects
Lowered white blood cell (leukopenia)Reduction of platelets in the bloodAllergic reactionDifficulty in breathingNumbness and hand pain (Carpal tunnel syndrome)DepressionHigh levels of liver enzymesDiarrhea, NauseaDepressionJoint and back painFatigueAbdomen painSwelling in hands and feetsMuscle painTingling, pain, coldness, weakness in parts of the hand.

Ahabir 500mg Tablet contains the active constituent abiraterone acetate. It is used in adult men to treat prostate cancer, which has spread to other parts of the body. It is usually given with steroid medication to lower the chances of side effects. When Ahabir 500mg Tablet is prescribed for an early stage of this disorder, it is used with testosterone lowering treatment. This medicine is not for use in women or children. Effective contraception must be taken throughout the treatment. This medicine contains lactose and sodium, inform your physician if you have lactose intolerance or on a salt control diet.

Uses
Treatment of prostate cancer

Storage
This medicine does not require any particular storage condition.

Side Effects
Low blood potassium levels (muscle weakness, muscle twitches, or pounding heartbeat)Fluid in legs or feetLow blood potassiumHigh blood pressureUrinary tract infectionDiarrheaHigh-fat levels in the bloodChest painIrregular heartbeatRapid heart rateBone fractureIndigestionBlood in urineRash

Bevetex 100mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count. 
This medicine is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.
Uses
Ovarian cancerBreast cancerNon-small cell lung cancerAIDS-related Kaposi’s sarcoma

Storage
Do not store above 25°C. 

Side Effects
Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)Severe diarrheaSevere stomach painAnemia, feeling tiredHair lossBurning, tingling, or numbness in your feet or handsMuscle and joint painVomiting, nauseaMouth or lip soresInfectionsSwelling of hands, feet, and faceBleedingIrritation at the injection siteLow blood pressure   

Cytax Nab100 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count. 
This medicine is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.

Uses
Ovarian cancerBreast cancerNon-small cell lung cancerAIDS-related Kaposi’s sarcoma

Storage  
Do not store above 25°C.
Keep out of sight and reach of children.  

Side Effects
Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)Severe diarrheaSevere stomach painAnemia, feeling tiredHair lossBurning, tingling, or numbness in your feet or handsMuscle and joint painVomiting, nauseaMouth or lip soresInfectionsSwelling of hands, feet, and faceBleedingIrritation at the injection siteLow blood pressure

Trabec 1MG Infusion contains the active ingredient Trabectedin. It is an antineoplastic drug that belongs to the class of medications called alkylating agents. It is used to treat liposarcoma (a type of cancer that starts in fat cells) or leiomyosarcoma (cancer that begins in smooth muscle tissue) that has spread to other parts of the body and cannot be treated with surgery in individuals who have already received treatment with certain anti-cancer medications. It is also indicated to treat ovarian cancer that has reoccurred after at least 1 previous therapy and not responding to other treatments.  
Do not take Trabec 1MG Infusion if you are allergic to Trabectedin or any other ingredients of this medicine, if you have serious infections, if you are breastfeeding, and if you will receive a yellow fever vaccine. Inform your physician if you have an active infection, or suffered from any infections, liver disease, kidney problems, or heart diseases. This medicine may impair fertility, discuss with your doctor before planning for pregnancy.

Uses
Liposarcoma  or Leiomyosarcoma   

Storage
Store Trabec 1MG Infusion in the refrigerator (2°C to 8°C)Do not freeze

Side Effects
ConstipationDecrease in appetiteDiarrheaNausea, vomitingAnemiaDecreased albumin levelsDecreased platelet countHeadacheShortness of breathTiredness Heart problemsSkin rashesLiver problemsSevere muscle pain  

Anvimo 240mg Tablet is an antiviral medication containing letermovir as its active ingredient. It belongs to the pharmacological class of antiviral agents and is specifically classified under cytomegalovirus (CMV) DNA terminase inhibitors. Anvimo 240mg Tablet is primarily used to prevent cytomegalovirus (CMV) infection in patients who have recently undergone an allogeneic hematopoietic stem cell transplant (HSCT) and are at a higher risk of CMV reactivation.
Anvimo 240mg Tablet works by inhibiting the CMV DNA terminase complex, which is crucial for viral replication. It is typically prescribed for CMV-seropositive adult patients post-transplant to reduce the likelihood of viral complications. However, the medication is not a treatment for existing CMV infections.
Patients taking this medication should follow strict safety precautions. It is contraindicated in individuals with known hypersensitivity to letermovir or any of its excipients. Additionally, it is not recommended for use with certain medications due to serious drug interactions. Healthcare professionals advise caution in pregnant or breastfeeding women, individuals with liver impairment, and those consuming alcohol.

Uses
Anvimo 240mg Tablet is FDA-approved for the prevention of cytomegalovirus (CMV) infection in adult patients who:
Have undergone allogeneic hematopoietic stem cell transplantation (HSCT)Are CMV-seropositive, meaning they have previously been exposed to the virusThis medication is used prophylactically and should not be used to treat an active CMV infection.

Storage
Keep the Anvimo 240mg tablet at room temperature (20-25°C), away from moisture and direct sunlight.Do not double-dose.Seek immediate medical attention if an overdose occurs. Symptoms may include severe nausea or irregular heartbeat.

Side Effects
NauseaFatigueHeadacheDiarrheaAbdominal painIrregular heartbeatSwelling in legs or feetUnexplained bleeding or bruisingSevere allergic reactions (rash, breathing difficulty)

Gefticip 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient, which the body is unable to digest. Lactose is a sugar found in milk and dairy products. It can cause symptoms such as bloating and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Uses
Non-small cell lung cancer.

Storage
Store Gefticip 250mg Tablet in the original package at room temperature (25°C).

Side Effects
DiarrheaNauseaVomitingLoss of appetiteWeaknessRed or sore mouthIncreased liver enzymesItchy or cracked skinDry mouthRed or itchy eyesNail problemsHair lossFeverBlood in the urine and a burning sensation while urinating

Letronat 2.5mg Tablet is an anticancer drug that contains the active ingredient letrozole and belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive. Since high amounts of estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of estrogen. This medicine aims to slow or stop the growth and/or spreading to other body parts.

Uses
First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer.Supportive to standard treatment for postmenopausal women with early breast cancer.Treatment for unknown advanced breast cancer in postmenopausal women.Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.

Storage
Store Letronat 2.5mg Tablets at an optimal temperature not exceeding 25°C.

Side Effects
Decreased red blood cellsDecreased bone mineral densityFluid build up in lungsSwelling in the face, eyes, feet, and legsHot sweats and excessive sweatingHypercholesterolemia (high cholesterol)ConstipationHeart palpilationHypertensionDiarrheaLoss of appetiteNausea and VomitingMuscle pain, bone pain, and joint stiffnessDizziness, tiredness, and sleepinessBreathing difficultyArthralgia

Rolimus 10mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumours are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma.
Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Rolimus 10mg tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine.

Uses
Advanced breast cancerAdvanced renal cell carcinomaAdvanced pancreatic neuroendocrine tumoursTreatment of subependymal giant cell astrocytoma

Storage
Store Rolimus 10mg tablet in the original package at room temperature (20°C to 25°C).

Side Effects
Difficulty breathing, or swallowingSwelling of face, lips, tongue, throatSevere itching, red rash, raised bumpsInfection (chills, increased temperature)CoughingWheezingExcessive thirstHigh urine output or severely decreased urine outputTirednessBleedingIncreased appetite with weight loss

Celrixafor 24mg injection is an antineoplastic containing the active ingredient Plerixafor. It is used in collecting blood stem cells, storage, and transplantation. It is also used in lymphoma (WBC cancer), multiple myeloma (plasma cell cancer in bone marrow), or a solid tumor. Talk to your doctor if you have or had any heart disease. Before starting the treatment, notify your doctor if you have high WBC counts, low platelet counts, or a history of usual lightheaded or fainting, especially before injection. It is not advised to take this medicine for stem cell mobilization if you have leukemia. 
Do not take this tablet if you are allergic to Plerixafor or any other medicine ingredients. Notify your doctor if you have kidney disorders; your doctor may adjust the dose of the Celrixafor 24mg if you have existing kidney disease. Your doctor may also perform a regular blood test to monitor the blood cell count. Do not take this tablet if you are pregnant or planning to get pregnant or think you might be pregnant, or if you are breastfeeding. It is recommended to use effective contraception. Report to your doctor if you experience any side effects like rashes or swelling around your eyes, a change in breathing (lack of oxygen), or pain in the abdomen (upper left) or left shoulder.

Uses
Collect blood stem cellsLymphoma and multiple myeloma in adultsLymphoma or solid tumors in children (aged between 1 to 18)

Storage
Store below 30°C

Side Effects
Rashes and swelling around the eyesDifficulty in breathingFaintnessUpper left abdomen painLeft shoulder painDiarrheaRedness or irritation in the injection siteLow RBC count (anemia)Constipation, indigestionDry mouth, numbnessJoint painsSweatingDifficulty in sleepingHeadache

Erlocip 150mg Tablet is an anticancer medicine. Cancer is an abnormal and uncontrolled multiplication of cells within the body. It is used in the treatment of patients with advanced or metastatic non-small cell lung cancer.It is also used in advanced or metastatic non-small cell lung cancer if the previous therapy failed to stop the disease. 
Erlocip 150mg Tablet is given in combination with Gemcitabine to treat pancreas cancer at the metastatic stage. Administration of this medicine may lead to kidney and liver failure. The doctor will periodically monitor kidney and liver function. Inform the physician about any history of clotting disorders or medicines taken for clotting disorders, as the Erlocip 150mg Tablet may increase the tendency to bleed.

Uses
Advanced or metastatic non-small lung cancer (NSCLC)Advanced or metastatic pancreatic cancer

Storage
Store at a controlled room temperature between 15°C to 30°C. Do not freeze.

Side Effects
Persistent or severe diarrheaPain in the eye, blurred visionsudden difficulty in breathing accompanied by cough and feversevere pain in your abdomenliver failureRash, worsened in sun-exposed areasLoss of appetite, decreased weightInfectionHeadache, changes in skin sensationDepressionNauseaMouth irritationIndigestion, stomach pain, buildup of gasHair loss, dry skin, itchingTiredness, feverAbnormal liver functionInflammation around fingernailacne, cracked skinbleeding from nose, stomach, intestinesreduced kidney function

Neukine 300mcg injection contains the active constituent filgrastim. It is a white blood cell growth factor (granulocyte-colony stimulating factor) approved by the FDA to decrease the risk of developing febrile neutropenia ( occurrence of fever or infection associated with low WBC count) and to reduce the duration of neutropenia (low white blood cell count) in people who have non-myeloid cancer and are receiving chemotherapy drugs. It is also used to increase the number of WBC and decrease the length of time of fever in people with acute myeloid leukemia. 
It is also used in people undergoing bone marrow transplants and in people with severe chronic neutropenia (low number of neutrophils in the blood). Neukine 300mcg injection is also used to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the blood). It is also indicated to increase the chance of survival in people exposed to harmful amounts of radiation, which can cause severe damage to the bone marrow. Other uses include in patients with advanced HIV infection, which will help to reduce the risk of infections.

Uses
To prevent infections after chemotherapy due to decreased white blood cells (neutropenia)

Storage
Store Neukine 300mcg injection in a refrigerator (2°C – 8°C). Do not freeze.

Side Effects
Pain in the bones, joints, and musclesPain at the site of InjectionFeverItchiness and skin rashNauseaHeadachesDizziness and tirednessNose bleedingHair fallInflammation of AortaCapillary leak syndrome (plasma leaks out of tiny blood vessels)Hypersensitivity reactionsChanges in urine colorSwelling in hands, feet, face, and abdomenDifficulty in breathingSickle cell anemia

Temoside 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temoside 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temoside 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temoside 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.

Uses
Treatment of newly diagnosed glioblastoma multiforme.Treatment of refractory anaplastic astrocytoma

Storage
Do not store above 25°C.

Side Effects
Secondary cancer like myelodysplastic syndrome and myeloid leukemia.Severe Allergic reactionsInflammation and fluid buildup in lungsBlood clot in lungs or legsLiver toxicityConvulsionsFever and chillsSevere headacheUncontrolled bleedingHair lossRashesTirednessNausea, vomiting and diarrheaConstipationHigh blood sugar levelsDizziness, impaired sensation, tingling sensation, abnormal tasteVision and Hearing problemFrequent urinationMuscle damage, pain in muscles and jointsWeight changesInfections and woundsAmnesiaAbnormal blood cell countsLoss of appetiteSleep problemsMemory lossDifficulty concentrating, changes in mental status and alertnessCoordination problems

Tegafi capsule is the combination of two medications called Tegafur +  Uracil. It is an anti-cancer medicine that belongs to the class of medication called pyrimidine analogs. It is indicated for the first-line treatment of metastatic colorectal cancer, along with other anti-cancer medications. Cancer is a condition in which cells multiply uncontrolled and abnormally. It is not recommended for adolescents and children. Avoid taking this medicine if you are pregnant or breastfeeding.   
Do not take Tegafi capsule if you are allergic to Tegafur +  Uracil or any other ingredients of this medicine. Inform your healthcare professional if you have liver diseases, kidney disorders, or other noncancerous conditions before initiating the treatment. This medicine may reduce fertility in men and women; discuss this with your doctor before starting the therapy. The most common side effects are diarrhea, nausea, vomiting, tiredness, and risk of infection. 

Uses
Colorectal cancer 

Storage 
Store at temperatures not exceeding 25°C

Side Effects
DiarrheaNausea, vomitingTirednessRisk of infectionFeverBruising and bleedingAnemiaChanges in skin and nailSwelling in the face, and bodySevere skin rashesSevere diarrheaLiver injury

D nib 50mg injection contains the active substance decitabine. It is an antineoplastic drug that belongs to the class of medications called DNA methylation inhibitors. It is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and do not produce enough healthy blood cells). It is also used to treat a type of cancer called acute myeloid leukemia (AML). It works by stopping the cancer cells from growing. 
Do not take this injection if you are allergic to decitabine or any other ingredients of this medicine. Inform your physician if you have an infection, decreased blood cell count, liver disease, kidney disorder, and a heart disorder. This medicine is not recommended for children or young people below 18 years of age. This medicine can cause a serious immune reaction called differentiation syndrome. Report to your physician if you face any symptoms of sudden difficulty in breathing, cough, fever, or swelling in the body.

Uses
Myelodysplastic syndromes (MDS)Acute myeloid leukemia (AML)

Storage
Do not store it above 25°CKeep the injection away from the reach of children and pets.    

Side Effects
Swelling in the face, hands, and feetSwelling and pain in the skinDiscoloration of the skinIncreased blood sugar levelsDecreased albumin levelsAbdominal pain, constipationDecrease in appetiteDiarrhea, indigestionNausea, vomitingInsomina, dizzinessPain in limbsHeart problemsAnemiaInfectionBleedingFluid in the lungsPneumonia

Cytodrox 500mg Capsule is an anticancer medication containing the active ingredient as Hydroxyurea. It is used to treat chronic myeloid leukemia (cancer of white blood cells) and polycythemia vera (cancer of red blood cells). The benefits of this medication include treating cancer by slowing down the growth and division of cancer cells and treating sickle cell anemia by reducing the frequency and severity of painful episodes and preventing organ damage. It is used to treat cervical, ovarian, and melanoma (skin cancer) and head and neck cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.
It is used to treat sickle cell anemia (an inherited blood disease in which healthy red blood cells are insufficient). This medication may be used to treat other conditions not mentioned here. You need to talk to your physician if you have any blood disorders, severe anemia, kidney disorders, liver disorders, gout, leg ulcers, folic acid deficiency, or have an intolerance to some sugars before taking Cytodrox 500mg Capsules.
Uses
Ovarian cancerPolycythemia veraChronic myeloid leukemiaCervical cancerHead and neck cancerSickle cell anemia

Storage Condition
Cytodrox 500mg Capsule should be stored at room temperature between 68°F to 77°F (20°C to 25°C).

Side Effects
Bone marrow suppression (decreased blood cell count)Skin reactions (rash, itching, and skin ulcers)Stevens-Johnson syndrome (life-threatening skin reaction)Tumor lysis syndrome (occur when large numbers of cancer cells are killed rapidly)Liver damage (jaundice, dark urine, pale stools, nausea, vomiting, and abdominal pain)Lung toxicity (shortness of breath, cough, fever, and chest pain)NauseaVomitingDiarrheaLoss of appetiteMouth soresHeadacheDizzinessFatigueSkin darkeningHair loss or thinningNail changesConstipation

Ben-C 167/1000mg capsule contains active components such as Curcumin. It is believed to have anti-inflammatory properties, which may help manage inflammatory conditions.  It possesses antioxidant properties, which can help neutralize harmful free radicals and reduce oxidative stress. Some studies suggest it may have analgesic (pain-relieving) effects, which could benefit conditions like arthritis. It has been explored for its potential to support digestive health and alleviate symptoms of conditions like irritable bowel syndrome (IBS). Some research suggests that it might have neuroprotective effects and could contribute to cognitive health. It's recommended to consult with a healthcare professional before starting, especially if you have pre-existing health conditions or are taking other medications. 
People with known allergies to Ben-C 167/1000mg capsule or related compounds should avoid this medication. Its immune-modulating properties may not suit individuals with autoimmune disorders, as it could exacerbate their condition. People with diabetes should monitor their blood sugar closely if they decide to use this medication and consult their healthcare provider for guidance.

Uses
ArthritisCancerInflammatory bowel disease (IBD)Alzheimer's diseaseHeart diseaseSkin conditionsMetabolic syndrome and diabetesImmune disordersLiver conditionsEye conditionsRespiratory conditionsJoint and bone healthAging-related concernsDepression and anxietyChronic pain management

Storage
Stored at room temperature from 20°C to 25°C. 

Side Effects
Allergic reactionsGastrointestinal issuesLiver toxicityBleeding riskGallbladder issuesIron absorptionDrug interactionsGastrointestinal distressNausea

Celkeran 2mg tablet contains the active ingredient chlorambucil. It is an anti-cancer medicine that belongs to the class of medications called alkylating agents. It is used to treat Hodgkin’s disease and non-hodgkin’s lymphoma (cancers formed from cells of the lymphatic system). It is also indicated to treat chronic lymphocytic leukemia (A type of WBC cancer, where the bone marrow produces a large number of abnormal cells) and Waldenstrom’s macroglobulinemia (A rare lymphoma associated with an uncontrolled increase of B-cells, a type of white blood cell, resulting in the release of an abnormal protein into the blood.) 
Do not take this medicine if you are allergic to Celkeran 2mg tablet or any of the ingredients. Inform the physician about your recent vaccination history, liver problems, kidney problems, and seizures. Notify the doctor if you have had radiotherapy or chemotherapy before or recently. It is possible that the use of this medicine, particularly in the long term, may increase the risk of developing secondary blood cancer.

Uses
Hodgkin's LymphomaNon-Hodgkin’s LymphomaChronic lymphocytic leukemiaWaldenstrom's macroglobulinemia

Storage
Store in a refrigerator (2 - 8°C).
Do not freeze.

Side Effects
AnemiaDecreased platelet countDecreased white blood cells Severe skin reactionsLiver toxicityHypersensitivity reactionSeizureHallucinationsInfertilityLung problems

Posid 50mg capsule is an anticancer drug with the ingredient Etoposide. It belongs to the medication class known as cytostatic. It is used to treat certain types of cancers such as testicular cancer, small-cell lung cancer, acute myeloid leukemia (blood cancer), tumor in the lymphatic system (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma), and ovarian cancer in adults.
Talk to your doctor if you had or currently having radiotherapy or chemotherapy. Report to your doctor if you have any infections or low levels of protein (albumin) in your blood. Posid 50mg capsule should not be taken if you have recently been vaccinated with yellow fever or any live vaccines. Before starting treatment with this medicine, it is very important to tell your physician if you currently or previously had any medical conditions of kidney problems or liver disorders.

Uses
Testicular cancerSmall-cell lung cancerAcute myeloid leukemia (blood cancer)Hodgkin’s lymphoma and non-Hodgkin’s lymphomaOvarian cancer

Storage
Store at a controlled room temperature between 15°C to 30°C.

Side Effects
Severe allergic reactions (swelling of tongue, or throat, breathing difficulties, rash, flushing, fast heartbeat)Irregular heartbeat (arrhythmia)Blood disorderHepatotoxicity (damage to the liver)Acute leukemiaNausea, vomitingLoss of appetiteAbdominal painConstipation, diarrheaChanges in skin colorWeaknessAsthenia (feeling weak)Temporary hair lossHigh or low blood pressureDizzinessRedness of the skinSore lips, throat, or mouth ulcers

Celkeran 5mg tablet contains the active ingredient chlorambucil. It is an anti-cancer medicine that belongs to the class of medications called alkylating agents. It is used to treat Hodgkin’s disease and non-hodgkin’s lymphoma (cancers formed from cells of the lymphatic system). It is also indicated to treat chronic lymphocytic leukemia (A type of WBC cancer, where the bone marrow produces a large number of abnormal cells) and Waldenstrom’s macroglobulinemia (A rare lymphoma associated with an uncontrolled increase of B-cells, a type of white blood cell, resulting in the release of an abnormal protein into the blood.) 
Do not take this medicine if you are allergic to Celkeran 5mg tablet or any of the ingredients. Inform the physician about your recent vaccination history, liver problems, kidney problems, and seizures. Notify the doctor if you have had radiotherapy or chemotherapy before or recently. It is possible that the use of this medicine, particularly in the long term, may increase the risk of developing secondary blood cancer.

Uses
Hodgkin's LymphomaNon-Hodgkin’s Lymphoma.Chronic lymphocytic leukemiaWaldenstrom's macroglobulinemia

Storage
Store in a refrigerator (2 and 8°C).  

Side Effects
AnemiaDecreased platelet countDecreased white blood cellsSevere skin reactionsLiver toxicityHypersensitivity reactionSeizureHallucinationsInfertilityLung problems